Aktis Oncology Raises $175 Million in Oversubscribed Series B Financing Round

Aktis Oncology concludes successful Series B financing round with $175 million raised from a diverse group of investors

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here